These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 11245465)

  • 1. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
    Rinaldi M; Fioretti D; Iurescia S; Signori E; Pierimarchi P; Seripa D; Tonon G; Fazio VM
    Biochem Biophys Res Commun; 2008 May; 370(2):279-84. PubMed ID: 18364239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma.
    Wen YJ; Lim SH
    Eur J Immunol; 1997 Apr; 27(4):1043-7. PubMed ID: 9130662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
    Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
    Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of heterologous antibodies specific for murine B-cell leukemia (BCL1) immunoglobulin by immunization with synthetic peptides homologous to heavy chain hypervariable regions.
    Smith LJ; Maloy WL; Braylan RC; Wakeland EK
    Cancer Res; 1985 Dec; 45(12 Pt 1):6119-23. PubMed ID: 3933821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
    Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
    J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
    Liu Y; Zhu P; Hu YM
    Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VH-related idiotopes detected by site-directed mutagenesis. A study induced by the failure to find CD4 anti-idiotypic antibodies mimicking the cellular receptor of HIV.
    Weissenhorn W; Chen YH; Riethmüller G; Rieber EP; Weiss EH
    J Immunol; 1992 Aug; 149(4):1237-41. PubMed ID: 1500715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
    Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
    Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
    Spellerberg MB; Zhu D; Thompsett A; King CA; Hamblin TJ; Stevenson FK
    J Immunol; 1997 Aug; 159(4):1885-92. PubMed ID: 9257853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.
    Benvenuti F; Burrone OR
    Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
    Zhong KL; Zhang WJ; Yuan Y; Wu Y; Zhang MW; Mao N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):609-15. PubMed ID: 14706145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific humoral immune response against B-cell lymphoma elicited by mixed immunoglobulin fragments].
    Lin N; Zhu P; Zhang X; Dong Y; Ren Y; Wang Y; Li W
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):766-70. PubMed ID: 12126549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.
    Benvenuti F; Burrone OR; Efremov DG
    Gene Ther; 2000 Apr; 7(7):605-11. PubMed ID: 10819576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on TCRbeta idiotypic antigenic determinants DNA vaccine to induce anti-lymphoma antibodies].
    Zhang Y; Zhu P; Shi Y; Liu J; Pu D; Cao X; Zhu Q; Wang Y; Ma M; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):68-72. PubMed ID: 12015073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-lymphoma immunity: relative efficacy of peptide and recombinant DNA vaccine.
    Lim SY; Laxmanan S; Stuart G; Ghosh SK
    Cancer Detect Prev; 2001; 25(5):470-8. PubMed ID: 11718453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.